Patient characteristics
| Patient ID . | Sex . | Race . | Plasma viral load, RNA copies/mL . | CD4 count, cells/mm3 . |
|---|---|---|---|---|
| Elite controllers | ||||
| 85 | M | W | < 75 | 883 |
| 1099 | M | B | < 75 | 139 |
| 1122 | M | W | < 75 | 884 |
| 1125 | F | B | < 75 | 765 |
| 1139 | M | NAm | < 75 | 536 |
| 1155 | M | B | < 75 | 225 |
| 1161 | M | W | < 75 | 912 |
| 1170 | M | As | < 75 | 535 |
| 1198 | M | W | < 75 | 1208 |
| 1203 | M | Mixed race | < 75 | 575 |
| 1511 | F | B | < 75 | 455 |
| 1517 | M | W | < 75 | 1537 |
| 1518 | T | B | < 75 | 1224 |
| 1529 | M | W | < 75 | 727 |
| 1545 | M | B | < 75 | 725 |
| 1552 | T | B | < 75 | 894 |
| 1555 | F | B | < 75 | 1115 |
| Group median | < 75 | 765 | ||
| Viremic controllers | ||||
| 50 | F | B | 140 | 619 |
| 1116 | M | W | 94 | 381 |
| 1119 | F | W | 209 | 1131 |
| 1127 | F | W | 1499 | 555 |
| 1128 | M | B | 546 | 398 |
| 1143 | M | W | 104 | 533 |
| 1148 | M | NAm | 426 | 389 |
| 1164 | M | Mixed race | 311 | 475 |
| 1181 | F | W | 2451 | 420 |
| 1516 | M | B | 104 | 657 |
| 4008 | M | W | 260 | 404 |
| Group median | 260 | 475 | ||
| Noncontrollers | ||||
| 56 | M | W | 38 441 | 304 |
| 58 | M | W | 44 956 | 538 |
| 65 | M | W | 31 975 | 719 |
| 66 | M | W | 42 049 | 481 |
| 67 | M | W | 13 582 | 715 |
| 98 | F | W | 34 882 | 608 |
| 118 | M | W | 36 286 | 289 |
| 1141 | M | H | 19 997 | 1123 |
| 1237 | M | W | > 50 118 | 564 |
| 1254 | F | B | > 50 118 | 242 |
| 1259 | M | B | > 50 118 | 275 |
| 1265 | F | Mixed race | 20 420 | 692 |
| 1275 | F | NAm | 23 205 | 347 |
| 1562 | T | B | 1108-25 115* | 474 |
| Group median | 35 584 | 510 | ||
| HAART-suppressed | ||||
| 54 | T | W | < 75 | 512 |
| 57 | M | W | < 75 | 442 |
| 63 | F | W | < 75 | 464 |
| 64 | M | W | < 75 | 851 |
| 77 | M | B | < 75 | 408 |
| 80 | M | W | < 75 | 927 |
| 83 | M | B | < 75 | 287 |
| 88 | M | W | < 75 | 316 |
| 92 | M | W | < 75 | 545 |
| 93 | F | W | < 75 | 809 |
| Group median | < 75 | 488 | ||
| Seronegatives | ||||
| 27 | M | B | < 75 | 837 |
| 74 | M | B | < 75 | 322 |
| 86 | F | B | < 75 | 670 |
| 87 | F | W | < 75 | 742 |
| 91 | F | W | < 75 | 714 |
| 94 | F | As | < 75 | 228 |
| 96 | M | B | < 75 | 1396 |
| 100 | M | Mixed race | < 75 | 609 |
| Group median | < 75 | 692 |
| Patient ID . | Sex . | Race . | Plasma viral load, RNA copies/mL . | CD4 count, cells/mm3 . |
|---|---|---|---|---|
| Elite controllers | ||||
| 85 | M | W | < 75 | 883 |
| 1099 | M | B | < 75 | 139 |
| 1122 | M | W | < 75 | 884 |
| 1125 | F | B | < 75 | 765 |
| 1139 | M | NAm | < 75 | 536 |
| 1155 | M | B | < 75 | 225 |
| 1161 | M | W | < 75 | 912 |
| 1170 | M | As | < 75 | 535 |
| 1198 | M | W | < 75 | 1208 |
| 1203 | M | Mixed race | < 75 | 575 |
| 1511 | F | B | < 75 | 455 |
| 1517 | M | W | < 75 | 1537 |
| 1518 | T | B | < 75 | 1224 |
| 1529 | M | W | < 75 | 727 |
| 1545 | M | B | < 75 | 725 |
| 1552 | T | B | < 75 | 894 |
| 1555 | F | B | < 75 | 1115 |
| Group median | < 75 | 765 | ||
| Viremic controllers | ||||
| 50 | F | B | 140 | 619 |
| 1116 | M | W | 94 | 381 |
| 1119 | F | W | 209 | 1131 |
| 1127 | F | W | 1499 | 555 |
| 1128 | M | B | 546 | 398 |
| 1143 | M | W | 104 | 533 |
| 1148 | M | NAm | 426 | 389 |
| 1164 | M | Mixed race | 311 | 475 |
| 1181 | F | W | 2451 | 420 |
| 1516 | M | B | 104 | 657 |
| 4008 | M | W | 260 | 404 |
| Group median | 260 | 475 | ||
| Noncontrollers | ||||
| 56 | M | W | 38 441 | 304 |
| 58 | M | W | 44 956 | 538 |
| 65 | M | W | 31 975 | 719 |
| 66 | M | W | 42 049 | 481 |
| 67 | M | W | 13 582 | 715 |
| 98 | F | W | 34 882 | 608 |
| 118 | M | W | 36 286 | 289 |
| 1141 | M | H | 19 997 | 1123 |
| 1237 | M | W | > 50 118 | 564 |
| 1254 | F | B | > 50 118 | 242 |
| 1259 | M | B | > 50 118 | 275 |
| 1265 | F | Mixed race | 20 420 | 692 |
| 1275 | F | NAm | 23 205 | 347 |
| 1562 | T | B | 1108-25 115* | 474 |
| Group median | 35 584 | 510 | ||
| HAART-suppressed | ||||
| 54 | T | W | < 75 | 512 |
| 57 | M | W | < 75 | 442 |
| 63 | F | W | < 75 | 464 |
| 64 | M | W | < 75 | 851 |
| 77 | M | B | < 75 | 408 |
| 80 | M | W | < 75 | 927 |
| 83 | M | B | < 75 | 287 |
| 88 | M | W | < 75 | 316 |
| 92 | M | W | < 75 | 545 |
| 93 | F | W | < 75 | 809 |
| Group median | < 75 | 488 | ||
| Seronegatives | ||||
| 27 | M | B | < 75 | 837 |
| 74 | M | B | < 75 | 322 |
| 86 | F | B | < 75 | 670 |
| 87 | F | W | < 75 | 742 |
| 91 | F | W | < 75 | 714 |
| 94 | F | As | < 75 | 228 |
| 96 | M | B | < 75 | 1396 |
| 100 | M | Mixed race | < 75 | 609 |
| Group median | < 75 | 692 |
M indicates male; F, female; T, transgender; W, white; B, black; NAm, Native American; As, Asian; and H, Hispanic.
Patient 1562: plasma viral load fluctuates. For the last 2 years, more than 50% of viral loads have been more than 23 000 copies/mL.